DE | Accessible presentation
Translations are powered by AI

The most important investments of the second quarter of 2022

Personio, Kinexon, and Finn – numerous Munich-based startups successfully raised fresh capital in the past three months. This photo gallery provides an overview of the largest investments in the second quarter of 2022.

July 5, 2022 3 min reading time

Tubules
60 million euros for Tubulis: The Munich-based biotech company Tubulis secured a Series B financing 60 million euros (63 million US dollars). The round was led by Andera Partners. Tubulis develops antibody-drug conjugates (ADCs) designed to target tumors. The Munich-based startup plans to use the fresh capital to advance development toward clinical evaluation. (Photo: Carolin Bleese)
read more ↓